Changes in myocardial iron content following administration of intravenous iron (Myocardial‐IRON): Study design

Treatment with intravenous ferric carboxymaltose (FCM) has been shown to improve symptoms, functional capacity, and quality of life in patients with heart failure and iron deficiency. However, the underlying mechanisms for these beneficial effects remain undetermined. The aim of this study is to qua...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Clin Cardiol
Autori principali: Miñana, Gema, Cardells, Ingrid, Palau, Patricia, Llàcer, Pau, Fácila, Lorenzo, Almenar, Luis, López‐Lereu, Maria Pilar, Monmeneu, Jose V., Amiguet, Martina, González, Jessika, Serrano, Alicia, Montagud, Vicente, López‐Vilella, Raquel, Valero, Ernesto, García‐Blas, Sergio, Bodí, Vicent, de la Espriella‐Juan, Rafael, Sanchis, Juan, Chorro, Francisco J., Bayés‐Genís, Antoni, Núñez, Julio
Natura: Artigo
Lingua:Inglês
Pubblicazione: Wiley Periodicals, Inc. 2018
Soggetti:
Trial Designs
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6489786/
https://ncbi.nlm.nih.gov/pubmed/29607528
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.22956
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi